Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy
Authors:
- Yuki KojimaYKYuki Kojima
- Kenji HashimotoKHKenji Hashimoto
- Masashi AndoMAMasashi Ando
- Akihiro HirakawaAHAkihiro Hirakawa
- Makoto KodairaMKMakoto Kodaira
- Mayu YunokawaMYMayu Yunokawa
- Chikako ShimizuCSChikako Shimizu
- Kenji TamuraKTKenji Tamura
- Noriyuki KatsumataNKNoriyuki Katsumata
- Atsushi MakimotoAMAtsushi Makimoto
- 23 March 2012
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 138 (7) , 1249-1257
Abstract
Outcomes in adult patients with rhabdomyosarcoma are poor, with a 5-year survival rate of approximately 30 %. The current study aimed to compare the clinical outcomes of adult and childhood rhabdomyosarcoma patients with local and metastatic disease and to examine the impact and timing of local therapy on metastasis.Keywords
This publication has 29 references indexed in Scilit:
- Local Therapy for Rhabdomyosarcoma of the Hands and Feet: Is Amputation Necessary? A Report From the Children's Oncology GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803—A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2010
- Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors CommitteeInternational Journal of Cancer, 2010
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803Journal of Clinical Oncology, 2009
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative GroupsJournal of Clinical Oncology, 2008
- Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the HD CWS‐96 trialPediatric Blood & Cancer, 2008
- Pediatric surgical oncology: Management of rhabdomyosarcomaSurgical Oncology, 2007
- Pooled Analysis of Phase II Window Studies in Children With Contemporary High-Risk Metastatic Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology GroupJournal of Clinical Oncology, 2006
- Group II Rhabdomyosarcoma and Rhabdomyosarcomalike Tumors: Is Radiotherapy Necessary?Journal of Clinical Oncology, 2004
- The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS‐I Through IRS‐IV Studies as Background for the Current IRS‐V Treatment ProtocolsSarcoma, 2001